Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Piramal Pharma Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹142.30 |
52 Week High | ₹149.00 |
52 Week Low | ₹70.14 |
Beta | 0 |
1 Month Change | 16.31% |
3 Month Change | -0.39% |
1 Year Change | 100.85% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -25.79% |
Recent News & Updates
Recent updates
Shareholder Returns
543635 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 2.0% | 2.3% | 2.6% |
1Y | 100.8% | 56.7% | 45.0% |
Return vs Industry: 543635 exceeded the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 543635 exceeded the Indian Market which returned 46.6% over the past year.
Price Volatility
543635 volatility | |
---|---|
543635 Average Weekly Movement | 4.6% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.8% |
10% most volatile stocks in IN Market | 10.0% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543635 has not had significant price volatility in the past 3 months.
Volatility Over Time: 543635's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | 6,295 | n/a | www.piramal.com/businesses/piramal-pharma/ |
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
Piramal Pharma Limited Fundamentals Summary
543635 fundamental statistics | |
---|---|
Market cap | ₹188.19b |
Earnings (TTM) | -₹333.40m |
Revenue (TTM) | ₹78.44b |
2.4x
P/S Ratio-564.5x
P/E RatioIs 543635 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
543635 income statement (TTM) | |
---|---|
Revenue | ₹78.44b |
Cost of Revenue | ₹30.47b |
Gross Profit | ₹47.96b |
Other Expenses | ₹48.30b |
Earnings | -₹333.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.25 |
Gross Margin | 61.15% |
Net Profit Margin | -0.43% |
Debt/Equity Ratio | 58.5% |
How did 543635 perform over the long term?
See historical performance and comparison